Brief: SkinBioTherapeutics HY26 Results Delayed Until Board Investigation Is Complete

Skinbiotherapeutics

20/03/2026 11:42

March 20 (Reuters) - SkinBioTherapeutics PLC SBTX.L:

SKINBIOTHERAPEUTICS - UPDATE ON BOARD INVESTIGATION AND INTERIMS DATE

SKINBIOTHERAPEUTICS PLC - HY26 RESULTS DELAYED UNTIL BOARD INVESTIGATION IS COMPLETE

SKINBIOTHERAPEUTICS PLC: EXPECTS THAT TRADING IN COMPANY'S ORDINARY SHARES WILL BE SUSPENDED WITH EFFECT FROM 7.30AM ON 1 APRIL 2026

SKINBIOTHERAPEUTICS: TRADING IN SHARES IS ANTICIPATED TO RESUME UPON FINALISATION OF BOARD INVESTIGATION AND PUBLICATION OF INTERIM RESULTS

Source text: ID:nRST5100Xa

Further company coverage: SBTX.L

 ((Reuters.Briefs@thomsonreuters.com))